Kymera Therapeutics
Sam Sparks is a Senior Scientist at Kymera Therapeutics since October 2022, previously serving as a Senior Investigator at Roivant Sciences from March 2021 to August 2022, where notable accomplishments included co-leading an early-stage portfolio program and managing CRO activities. Prior experience includes a Senior Investigator role at Silicon Therapeutics, focusing on integrating biophysical data with molecular simulations and performing binding studies, and a postdoctoral researcher position at Albert Einstein College of Medicine. Sam Sparks completed a Ph.D. in Biochemistry at Albert Einstein College of Medicine, complemented by a Master of Arts in Chemistry and a BA in Chemistry from Clark University.
Kymera Therapeutics
6 followers
Kymera is a clinical stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.